BDPT — BioAdaptives Cashflow Statement
0.000.00%
Last trade - 00:00- $0.65m
- $0.95m
- $0.03m
Annual cashflow statement for BioAdaptives, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.239 | -0.847 | -1.05 | -0.896 | -0.712 |
| Amortisation | |||||
| Non-Cash Items | 0.056 | 0.682 | 0.522 | 0.424 | 0.44 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.015 | 0.058 | 0.235 | 0.182 | 0.02 |
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.168 | -0.107 | -0.159 | -0.227 | -0.224 |
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | 0 | — | — | — | — |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.124 | 0.099 | 0.237 | 0.17 | 0.259 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.044 | -0.008 | 0.078 | -0.058 | 0.035 |